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Abstract: OBJECTIVE Comorbid mental disorders in anorexia nervosa during long-term course require
detailed studies. METHOD This matched cohort study was based on nationwide Danish register data
of all patients born 1961-2008 with a first-time ICD-10 diagnosis of anorexia nervosa (AN) between 1994
and 2018 at age 8-32 and matched controls taken from all individuals without an eating disorder (ED).
For nine categories of non-eating mental disorders, time from date of first AN-diagnosis (inclusion date)
to time of first diagnosis, accounting for censoring, was studied by use of time-stratified Cox models.
RESULTS A total of 9,985 patients with AN (93.5% females) and 49,351 matched controls were followed
for a median (IQR) of 9.0 (4.4-15.7) years. For patients, there was about 25% and 55% risk of receiving
any non-ED disorder during the first 2 years and two decades after inclusion, respectively. A hazard ratio
(HR) of seven for any non-ED was found for the first 12 months after inclusion, a ratio that reduced to
two at five or more years after inclusion. During the first years, large HRs ranging in 6-9 were found
for affective, autism spectrum, personality, and obsessive-compulsive disorders with the latter displaying
the highest continuous increased risk. The HR at 12 months after inclusion was highest for any non-
ED disorder and affective disorders in patients aged 8-13 at diagnosis. DISCUSSION Comorbid mental
disorders in AN are most frequently diagnosed in the first years after diagnosis of AN and on longer terms
imply a double immediate risk.
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Abstract
Objective: Comorbid mental disorders in anorexia nervosa during long-term course
require detailed studies.
Method: This matched cohort study was based on nationwide Danish register data
of all patients born 1961–2008 with a first-time ICD-10 diagnosis of anorexia
nervosa (AN) between 1994 and 2018 at age 8–32 and matched controls taken from
all individuals without an eating disorder (ED). For nine categories of non-eating men-
tal disorders, time from date of first AN-diagnosis (inclusion date) to time of first
diagnosis, accounting for censoring, was studied by use of time-stratified Cox
models.
Results: A total of 9,985 patients with AN (93.5% females) and 49,351 matched con-
trols were followed for a median (IQR) of 9.0 (4.4–15.7) years. For patients, there
was about 25% and 55% risk of receiving any non-ED disorder during the first
2 years and two decades after inclusion, respectively. A hazard ratio (HR) of seven
for any non-ED was found for the first 12 months after inclusion, a ratio that reduced
to two at five or more years after inclusion. During the first years, large HRs ranging
in 6–9 were found for affective, autism spectrum, personality, and obsessive–
compulsive disorders with the latter displaying the highest continuous increased risk.
The HR at 12 months after inclusion was highest for any non-ED disorder and affec-
tive disorders in patients aged 8–13 at diagnosis.
Discussion: Comorbid mental disorders in AN are most frequently diagnosed in the
first years after diagnosis of AN and on longer terms imply a double immediate risk.
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1 | INTRODUCTION
Anorexia nervosa (AN) commonly cooccurs with other mental disor-
ders (Demmler, Brophy, Marchant, John, & Tan, 2020; Hudson, Hiripi,
Pope, & Kessler, 2007; Keski-Rahkonen & Mustelin, 2016; Tsai
et al., 2018; Udo & Grilo, 2019; Ulfvebrand, Birgegard, Norring,
Hogdahl, & von Hausswolff-Juhlin, 2015). These most commonly
include anxiety disorders (Meier et al., 2015), depression (Carrot
et al., 2017), obsessive–compulsive disorders (OCD) (Meier
et al., 2015; Yilmaz et al., 2020), substance use disorders (Fouladi
et al., 2015; Root et al., 2010), personality disorders (Martinussen
et al., 2017; von Lojewski, Fisher, & Abraham, 2013), autism spectrum
disorders (Koch et al., 2015; Wentz, Gillberg, Anckarsater, Gillberg, &
Rastam, 2009; Westwood & Tchanturia, 2017), and attention-deficit-
hyperactivity disorder (Nazar et al., 2016). In addition, mortality is
markedly increased in AN with the presence of mental health comor-
bidity (Himmerich et al., 2019; Kask et al., 2016).
A systematic review of all long-term follow-up studies of the clini-
cal course of AN performed in the 20th century reported a variety of
comorbid disorders including anxiety disorders and phobias (25.5%),
affective disorders (24.1%), substance use disorders (14.4%),
obsessive–compulsive disorders (12.2%), and various personality dis-
orders (16.6–31.4%) (Steinhausen, 2002). More recent follow-up stud-
ies have revealed that comorbid depression at the start of treatment
is a negative predictor of outcome for the restrictive type of AN
(Eskild-Jensen, Stoving, Flindt, & Sjogren, 2020; Franko et al., 2018),
and that OCD is both a frequent life-time and follow-up diagnosis
(Mandelli, Draghetti, Albert, De Ronchi, & Atti, 2020). Both OCD
(Mandelli et al., 2020) and autistic traits are also associated with a less
favorable outcome (Wentz et al., 2009). At the 5–10-year follow-up,
28% of patients with a childhood onset of AN had a current comor-
bidity and 64% had a past comorbid diagnosis (Herpertz-Dahlmann
et al., 2018).
Age of onset has been shown to have an effect on outcome. In
particular, onset of AN during adolescence was associated with
a more benign outcome in a sizeable number of outcome
studies (Steinhausen, 2002; Steinhausen, Boyadjieva, Griogoroiu-
Serbanescu, & Neumarker, 2003). None of these studies consid-
ered the association between AN and comorbid mental disorders
concurrent or subsequent to the AN diagnosis as outcomes.
Further, previous research has not accounted for the risk in con-
trols, implying that the reported results may to some degree reflect
common challenges in adolescent life.
The present report is part of a multi-domain study of the long-
term course of a nationwide Danish cohort of patients with AN
compared to matched controls. In the entire set of analyses, a spe-
cific focus is on the effect of age at diagnosis as the best proxy of
age at onset of AN. The aim of this study was to investigate
whether concurrent and subsequent mental disorders during long-
term follow-up are more frequent and differ across time in AN
patients compared to controls, and whether age at diagnosis of AN
modifies the association.
2 | METHOD
2.1 | Study samples
The study was based on the complete nationwide cohort of all indi-
viduals born 1961–2008 who were diagnosed with an eating disor-
der (ED) in 1994–2018 and at the time of the first diagnosis were
at age 8–32 years. EDs were defined by the International Classifica-
tion of Diseases and Related Health Problems, 10th edition
(WHO, 1992), code F50 in the National Patient Register (NPR).
Patients with AN (F50.0, F50.1) were identified in the registers as
individuals with at least one AN diagnosis at the first day of regis-
tration with a non-emergency incident ED diagnosis, regardless of
whether the patient simultaneously had a diagnosis of bulimia
nervosa. The age range of the sample was guided by the idea that
the validity of the diagnosis of AN is uncertain outside this age
range. Based on studies analyzing childhood AN (see Herpertz-
Dahlmann et al., 2018), we decided to truncate the empirical distri-
bution at the lower age of 8 years at first diagnosis. The upper age
at first diagnosis limitation was guided by the following consider-
ations. First, it is questionable whether late onset exists or is due to
late diagnosis (Scholtz, Hill, & Lacey, 2010). Secondly, in a previous
study on life-time incidence rates of first-time diagnosed AN up to
age 65 based on Danish registry data, we found a sharp decline of
incidences starting with the age-group 30–39 (Scholtz et al., 2010;
Steinhausen & Jensen, 2015).
To avoid prevalent cases from being classified as incident cases,
all patients with access to services before 1994 were excluded by
study design. This procedure, which was used separately for each dis-
order, implies an exclusion of all patients and controls with the ICD-8
classification. In Denmark, the ICD-8 classification was used from
1969 to 1993, the ICD-9 was never adopted, and the ICD-10 was
used from 1994.
Using a matched design with a 1:5 ratio, controls alive at the time
of inclusion of matched patients were identified via the Danish Civil
Registration System (DCRS), which covers the total general popula-
tion. The date of the first AN-diagnosis defines the inclusion date for
both the patients and the controls. The matching was done on sex,
age, and area of residence at the time of the first eating disorder diag-
nosis in the patients. By design, controls did not have any ED diagno-
sis prior to or at any time after inclusion. All participants were alive,
and resided in Denmark at the initiation of follow-up.
Figure 1 presents a flowchart of the sample populations. Starting
from 27,134 individuals with an eating disorder and 133,866 controls,
the final sample amounted to 9,985 patients with anorexia nervosa
(F 50.0 anorexia nervosa and F 50.1 atypical anorexia nervosa) and to
49,351 controls. The sample was divided into three subgroups by age
in years at first diagnosis of anorexia nervosa, covering 8–13, 14–17,
and 18–32 at the time of inclusion. The three subgroups were defined
according to common developmental distinctions between childhood
including preadolescence (age 8–13), adolescence (age 14–17), and
adulthood (age 18 and older).
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2.2 | Procedure
The study was based on the comprehensive Danish system of registries,
which includes mandatory recording of patient visits to the public health
service. The system covers various domains of data collection including
extensive health information on the total national population since 1968
(Pedersen, 2011). In the present study, based on the personal identifica-
tion number (CPR) assigned to all Danish citizens and residents, informa-
tion was collected from the DCRS on date of birth, sex, postcode of
residence at the time of the first diagnosis in the NPR. Furthermore, data
on mental disorders including first-time AN diagnosis, time and type of
admission to psychiatric facilities, and information regarding parental
mental health were collected from the Danish Psychiatric Central
Research Register (DPCRR) (Mors, Perto, & Mortensen, 2011). Addi-
tional information on family income as an indicator of socioeconomic
status was collected from the Income Statistics Register. Data were pro-
vided by Statistics Denmark in an anonymized fashion and approval of
the study was given by the Danish Data Protection Agency (file
no. 15/280490). According to Danish law, ethical approval is not
required for registry-based studies. Access to the data requires applica-
tion to the Danish authorities.
2.3 | Diagnoses
With a focus on concurrent and subsequent mental disorders in
AN-patients and matched controls during long-term follow-up, the
following nine major categories of mental disorders in the Interna-
tional Classification of Diseases (WHO, 1992) were considered in the
analyses: any non-ED (F00–F49 + F51–F99), substance use disorders
(F10–F19), schizophrenia or psychosis (F20–F29), affective disorders
(F38–F39), phobia or anxiety disorders (F40, F41), obsessive–
compulsive disorders (F42), adjustment disorders (F43), personality
disorders (F60–F69), and autism spectrum disorders (F84.0 + F84.1
+ F84.5). Frequencies of non-emergency incident disorders were
obtained both for the two-year period prior to inclusion and during
follow-up. All diagnoses were made by the attending physicians.
2.4 | Statistical analyses
Using Cox proportional hazards models with cluster robust standard
errors, time from first AN-diagnosis to first diagnosis, accounting for cen-
soring, was investigated for each of the nine mental disorders on the
matched cohort data. Separate effects were estimated on periods for
which time-invariance was assessed with Aalen's linear hazard models
(Lee & Weissfeld, 1998). The Cox models were adjusted for previous
mental diagnosis during the 2 years prior to inclusion, sex, study period
at time of inclusion (1994–1999, 2000–2004, 2005–2009, 2010–2014,
2015–2018), family income (in tertiles), and parental previous mental dis-
order at the time of inclusion. The assumptions of proportional hazards
were verified via Schoenfeld residuals tests. Tests for interaction
between age group and anorexia nervosa (patients vs. controls) for each
mental disorder were conducted. The method proposed by Holm (1979)
was used to correct for multiple testing. The risk of each of the nine
mental disorders over time in patients and controls were compared using
cumulative incidences, with death as competing risk, for each age-
subgroups as well as the combined sample. To guarantee anonymity of
individuals, cumulative incidences are graphed after applying a multiplica-
tive distortion of a Gaussian distributed random error with mean 1 and
SD 0.05. All analyses were performed with Stata 16.1 (Statacorp, College
Station, TX) on servers at Statistics Denmark.
3 | RESULTS
The baseline characteristics of each group are shown in Table 1.
Patients with anorexia nervosa were predominantly female (93.5%).
F IGURE 1 Flowchart for
identification of the study population
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The largest age group (45%) was 18–32 years old, while 38% were
14–17 and 17% were 8–13 years old. Median (IQR) follow-up time in
years for the two samples was 9.0 (4.4–15.7). At the time of study
inclusion, the AN sample consisted of 1,349 (13.5%) inpatients, 8, 595
(86.1%) outpatients and a negligible number of 41 patients in a day-
clinic (0.4%). As controls were matched on age listed in years, the age
at inclusion for controls exceeds the age range 8–32 (range 7.6–33.9).
A higher proportion of patients with AN than controls (12.7%
vs. 3.6%) had a mental diagnosis in the 2 years prior to inclusion, but
frequencies of the various other mental disorders in the two samples
prior to inclusion were rather low. Among patients and controls, 0.7%
respectively 0.2% were lost because of death.
For documentation, regardless of censored individuals, the fre-
quencies of mental disorders other than AN for the entire observation
period for the total samples and the various age groups are listed in
Table S1. Cumulative incidence curves for each of the nine mental dis-
orders for patients and controls are collected with Figure 2 for the
total sample and with Figure 3 for the three age groups 8–13, 14–17,
and 18–32. Table 2 lists cumulative incidences at selected time points
for non-ED disorders in the total and age stratified samples of patients
and controls. More than double cumulative incidence was observed at
any time during follow-up for patients when compared to controls in
each stratum. For example, at 4, 10, and 22 years the cumulative inci-
dence (95% CI) for the total sample of patients was 32.1% (31.0%–
33.3%), 44.3% (42.9%–45.6%), and 56.1% (54.2%–57.9%), while for
controls it was 7.70% (7.46%–7.95%), 15.4 (15.0%–15.7%), and
25.0% (24.3%–25.6%).
For each of the nine categories of mental disorders, Table 3
shows HRs for patients compared to controls for the total sample and
the three age groups 8–13, 14–17, and 18–32. For all mental groups
and on each stratum, the HRs were larger when closer to inclusion
while reduced to about two to three in the long term. For example,
for any non-ED mental disorder during the first 12 months the hazard
ratios were HR = 17.4 (95% CI, 14.0–21.7) and HR = 5.04 (95% CI,
4.42–5.75) for patients aged 8–13 and 18–32 at inclusion, respec-
tively, while at five or more years the two ratios had reduced to
HR = 2.17 (95% CI, 1.78–2.65) and HR = 2.02 (95% CI, 1.77–2.31),
respectively. During the first 2 years, a HR larger than nine was found
for affective, obsessive–compulsive, and personality disorders in the
age group 8–13. In the combined sample, large HRs ranging in 6–9
during the first years were found for affective, obsessive–compulsive,
any non-ED mental, autism spectrum, and personality disorders. There
were no indications of non-proportional hazards (p > .70) for any dis-
order. Differences across age groups pertained to any non-ED mental,
obsessive–compulsive, affective, and adjustment disorders at the first
years after inclusion with higher HR for the age groups 8–13 and
lower HR for the age group 18–32.
4 | DISCUSSION
The present study used a large nationwide sample of patients with
AN followed-up with a median duration of 9.0 years. The findings
contribute to the more limited findings based on previous observa-
tions made in follow-up studies of rather small clinical samples with
varying follow-up periods, and mostly without any controls, that never
considered analyses in a time-to-event setting.
In the present study, there was about a 25% and a 55% risk of
receiving any non-ED disorder for the patients during the first 2 years




Female 9,331 (93.5) 46,103 (93.4)
Male 654 (6.5) 3,248 (6.6)
Age in years at inclusion,
median (IQR)
17.3 (14.7–21.3) 17.3 (14.7–21.3)
Age groups in years
8–13 1724 (17.3) 8,519 (17.3)
14–17 3,809 (38.1) 18,848 (38.2)
18–32 4,452 (44.6) 21,984 (44.5)
Previous other mental disorders, no. (%)
Any non-ED disorder 1,273 (12.7) 1759 (3.6)
Substance use disorders 159 (1.6) 334 (0.7)
Schizophrenia or
psychosis
121 (1.2) 145 (0.3)
Affective disorders, no.
(%)
391 (3.9) 414 (0.8)
Phobia and anxiety
disorders
159 (1.6) 243 (0.5)
Obsessive–compulsive
disorders
101 (1.0) 91 (0.2)
Adjustment disorders 409 (4.1) 546 (1.1)
Personality disorders 234 (2.3) 244 (0.5)
Autism spectrum
disorders
58 (0.6) 87 (0.2)
Family income group (tertiles)
Lower tertile 3,477 (34.8) 16,301 (33.0)
Middle tertile 3,011 (30.2) 16,768 (34.0)
Higher tertile 3,497 (35.0) 16,282 (33.0)
Previous mental disorders of parents, no. (%)
None 7,827 (78.4) 40,150 (81.4)
1+ diagnoses in single
parent
1890 (18.9) 8,007 (16.2)
1+ diagnoses in both
parent
268 (2.7) 1,194 (2.4)
Period of inclusion, no. (%)
1994–1999 1,441 (14.4) 7,075 (14.3)
2000–2004 1,595 (16.0) 7,835 (15.9)
2005–2009 1971 (19.7) 9,726 (19.7)
2010–2014 2,725 (27.3) 13,537 (27.4)
2015–2018 2,253 (22.6) 11,178 (22.6)
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and two decades after inclusion, respectively. A HR of seven for any
non-ED was found for the first 12 months after inclusion, a ratio that
reduced to two at five or more years after inclusion. During the first
years after inclusion, large HRs ranging in 6–9 were found for affec-
tive, autism spectrum, personality, and obsessive–compulsive disor-
ders with the latter displaying the highest continuous increased risk.
The HR at 12 months after inclusion was highest for any non-ED dis-
order and affective disorders in patients aged 8–13 at diagnosis.
The findings of this study reflect a pronounced overall diagnosed
psychiatric comorbidity in AN across time. For patients, one out of
three was assigned at least one mental disorder in the 4 years after
receiving their first AN diagnosis, while it was only eight out of
100 for the controls. Cumulative incidences of eight major categories
of mental disorders among patients showed notable increased risks
over time for patients compared to controls. The immediate risks were
always at double or more when compared to controls and for some
disorders with much larger HR when close to inclusion, particularly for
the age group 8–13. For example, for any non-ED the HR was at
seven during the first 12 months after inclusion and reduced to two
at 5 years after inclusion. Close to inclusion, controls were at lower
risk of any non-ED at young age than at older age, while a subdued
but reversed pattern was found for the patients, leading to particular
high HR close to inclusion for the age group 8–13.
This marked burden imposed on individuals with AN by addi-
tional mental disorders at the time of, and soon after, the first AN
diagnosis is reflected in Figure 2 by the shape of the curves for
cumulative incidences. Among the matched controls, the cumula-
tive incidences increased to about 10% after 20 years for affective
and adjustment disorders and were lower for the remaining six
disorders.
The steep increase in risk of subsequent mental disorders in all
three age groups of patients with AN, and the high immediate risk
when compared to controls, near the time of inclusion is in parallel to
the often life-threatening and highly complicated clinical picture of
AN at first presentation. These observations about the temporal
sequence provide information that goes beyond the findings of a
heightened general risk of comorbid mental disorders as generated by
previous studies (Demmler et al., 2020; Hudson et al., 2007; Keski-
Rahkonen & Mustelin, 2016; Marucci et al., 2018; Steinhausen, 2002;
Tsai et al., 2018; Udo & Grilo, 2019; Ulfvebrand et al., 2015) and indi-
cate that AN in most instances is a multifaceted disorder that requires
complex interventions. On the other hand, these findings correspond
to the recent conclusion from a Danish national population study that
comorbidity within mental disorders is pervasive (Plana-Ripoll
et al., 2019).
In addition to these general patterns of cumulative incidences,
age at diagnosis proved to have a relevant impact on the occur-
rence of comorbid disorders for patients with AN. It was particu-
larly the youngest age group with a diagnosis of AN as early as age
8–13 that had the highest hazards when compared to controls for
any non-ED, obsessive–compulsive disorders, affective disorders,
and adjustment disorders while the ratios were lower for those
who were diagnosed only later at age 18–32. While it cannot be
ruled out that different traditions and concepts of training in
assessment as performed by child and adolescent psychiatrists ver-
sus adult psychiatrists may have contributed to this age effect,
these findings point to the high vulnerability of the youngest group
and also represent a more precise definition of the age at risk than
described before in the literature on outcome of AN
(Steinhausen, 2002). Obviously, the common distinction of age at
onset in adolescence, that is, <18 years of age, versus adult age is
not precise enough. However, it has to be admitted that the com-
mon reference to age at onset with its retrospective nature of defi-
nition may not have been used precisely enough in many of the
older studies so that the term of age at diagnosis used in the pre-
sent study is definitely more valid.
Furthermore, our study found that the hazard of being assigned a
comorbid psychiatric diagnosis was declining in patients with AN com-
pared to controls over a 20-year period after inclusion. The HRs
declined with length of follow-up time, indicating, in line with the
shape of the cumulative incidence curves, that the burden of comor-
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F IGURE 2 Cumulative incidences for other mental disorders of patients with AN and Controls in the two samples
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duration of the main disorder but that the risk over 20 years is always
at double or more. This finding represents an important extension of
the observation that a large proportion of patients with AN suffered
from comorbid mental disorders at single follow-up examinations in
the most comprehensive review of studies on the course of the disor-
der (Steinhausen, 2002).
In summary, the present findings may be regarded as coming from
the most representative presentation of various comorbid disorders
of AN in a single study. They extend the findings of a series of
previous studies that focused predominantly on the prevalence rather
than the incidence of single disorders in relatively small samples either
at clinical intake or in uncontrolled follow-ups (Carrot et al., 2017;
Fouladi et al., 2015; Franko et al., 2018; Herpertz-Dahlmann
et al., 2018; Koch et al., 2015; Martinussen et al., 2017; Meier
et al., 2015; Nazar et al., 2016; Root et al., 2010; von Lojewski
et al., 2013; Wentz et al., 2009; Westwood & Tchanturia, 2017;
Yilmaz et al., 2020) so that direct comparisons with the results of
these studies are hampered.
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F IGURE 3 Cumulative incidences for other mental disorders of patients with AN and Controls stratified for age
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It is noteworthy that the findings of the present study converge
with the idea of genetic overlaps between AN and various comorbid
psychiatric conditions. In fact, a recent genome-wide association
study (GWAS) showed significant correlations of AN with psychiatric
disorders (Watson et al., 2019). Further strengths of the present study
are the aforementioned characteristics of the design with large
nationwide samples including patients and well-matched controls and
long median follow-up. Free access to psychiatric institutions without
individual costs as a part of the national health service and GPs
referring patients with AN and other mental disorders mostly to psy-
chiatry contribute to the representativeness of the samples. Further-
more, the findings were adjusted for various potential confounders
including age, sex, area of residence, previous mental diagnoses of AN
patients and controls, period of inclusion, family income at baseline,
and previous mental disorders of parents.
Limitations include the structure of the NPR in general and the
DPCRR in particular. These registries do not contain information at
discharge or at the end of the treatment period. Thus, no precise
TABLE 3 Hazard ratios (HR) (95% CI) of other mental disorders during follow-up for patients with anorexia nervosa compared to controls
All Age 8–13 Age 14–17 Age 18–32 Interaction
N Patients n = 9,985,
controls, n = 49,351
Patients n = 1724,
controls, n = 8,519
Patients n = 3,809,
controls, n = 18,848
Patients n = 4,452,
controls, n = 21,984
HRa (95% CI) HRa (95% CI) HRa (95% CI) HRa (95% CI)
Any non-ED mental disorder
Months after inclusion: 0–12 7.47 (6.86–8.14) 17.4 (14.0–21.7) 8.29 (7.26–9.47) 5.04 (4.42–5.75) p < .001
Years after inclusion: 1–4 3.25 (3.02–3.51) 3.59 (3.01–4.28) 3.05 (2.71–3.42) 3.43 (3.08–3.86) c
Years after inclusion: 5+ 2.05 (1.88–2.24) 2.17 (1.78–2.65) 2.04 (1.76–2.35) 2.02 (1.77–2.31) c
Substance use disorders
Years after inclusion: 0–1 2.45 (2.05–2.93) 2.36 (1.20–4.66) 2.42 (1.87–3.13) 2.54 (1.99–3.24) c
Years after inclusion: 2–11 1.96 (1.75–2.19) 1.62 (1.26–2.08) 1.77 (1.50–2.10) 2.43 (2.05–2.89) c
Years after inclusion: 12+ 1.81 (1.38–2.37) 1.40 (0.66–2.97) 1.93 (1.15–3.22) 1.86 (1.30–2.67) c
Schizophrenia or psychosis
Years after inclusion: 0–3 4.60 (3.87–5.47) 6.43 (3.97–10.4) 5.17 (4.04–6.63) 3.96 (3.12–5.03) c
Years after inclusion: 4+ 2.74 (2.28–3.30) 3.38 (2.3–4.84) 2.38 (1.76–3.13) 2.82 (2.10–3.77) c
Affective disorders
Years after inclusion: 0–12 8.03 (6.86–9.41) 21.2 (12.5–35.8) 8.97 (7.15–11.25) 5.91 (4.73–7.37) p < .001
Years after inclusion: 1–4 3.43 (3.07–3.83) 4.29 (3.19–5.76) 3.77 (3.20–4.43) 3.00 (2.55–3.52) c
Years after inclusion: 5+ 2.45 (2.22–2.69) 2.78 (2.24–3.45) 2.39 (2.04–2.79) 2.34 (2.03–2.71) c
Phobia or anxiety disorders
Years after inclusion: 0–5 3.07 (2.73–3.47) 3.68 (2.71–4.99) 2.84 (2.37–3.40) 3.15 (2.66–3.73) c
Years after inclusion: 6+ 2.25 (1.98–2.56) 2.59 (1.96–3.42) 1.91 (1.56–2.35) 2.43 (1.99–2.95) c
Obsessive–compulsive disorders
Years after inclusion: 0–2 8.02 (6.47–9.93) 16.0 (10.4–24.5) 7.30 (5.41–9.85) 5.01 (3.46–7.25) p < .01
Years after inclusion: 3+ 5.98 (4.95–7.22) 7.37 (4.96–11.0) 6.00 (4.49–8.02) 5.27 (3.91–7.11) c
Adjustment disorders+
Years after inclusion: 0–2 3.88 (3.50–4.31) 6.17 (4.87–7.80) 4.01 (3.45–4.66) 3.18 (2.71–3.74) p < .001
Years after inclusion: 3+ 2.28 (2.08–2.50) 2.87 (2.08–3.18) 2.24 (1.93–2.59) 2.23 (1.98–2.55) c
Personality disorders
Years after inclusion: 0–2 6.28 (5.52–7.15) 9.53 (5.81–15.7) 6.49 (5.29–7.96) 6.00 (5.08–7.07) c
Years after inclusion: 3–12 3.83 (3.42–4.29) 3.27 (2.54–4.21) 3.76 (3.20–4.41) 4.15 (3.44–5.00) c
Years after inclusion: 13+ 2.93 (2.25–3.82) 3.75 (1.98–7.10) 3.28 (2.20–4.88) 2.40 (1.60–3.61) c
Autism spectrum disorders
Months after inclusion: 0–12 8.92 (6.06–13.0) b b b
Years after inclusion: 13 2.94 (2.25–3.86) b b b
aAdjusted for period of inclusion, sex, any mental diagnoses in the child during the last 2 years prior to inclusion, family income at baseline (in tertiles), and
previous mental disorders for parents at baseline (at least one diagnoses in at least one parent).
bToo few ASD-observations to fit proportional hazards model.
cp > .05.
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information on the course of AN is available, and therefore questions
regarding rates of recovery, improvement, chronicity or general out-
come of AN cannot be answered by the present study. However, the
focus of the present study was on comorbidity rather than on out-
come of AN. Furthermore, because ICD classifies ED differently to
the Diagnostic and Statistical Manual (DSM) and the information on
the subtype of AN in the register can be ambiguous, the association
of bulimic features in AN with other comorbid psychopathology can-
not be tested. Other issues not addressed by the present study are
the stability of the AN diagnosis across follow-up time, the rates of
diagnostic crossover within the spectrum of ED, and the impact of the
clinical setting in which the first observed AN occurred.
Furthermore, the steep increase in the cumulative incidence func-
tions of comorbid mental disorders in the patients with AN may indi-
cate increased surveillance for other disorders at inclusion and shortly
following the first AN diagnosis, but not later in time. However, con-
current comorbidity may also match the severity of the patient symp-
toms at this time during the course of AN as many of these patients
have a protracted onset of treatment that may increase severity and
chronicity of the disorder (Lock, La Via, & American Academy of Child
and Adolescent Psychiatry Committee on Quality Issues, 2016). In the
controls, there was also a steady increase in non-ED mental disorders
but on a much smaller level than in the patients. However, one might
argue that the rather strict inclusion criterion in the controls of not
having an ED diagnosis at any time of the follow-up period might have
resulted in a bias toward lower morbidity rates in this sample. Given
the rather low incidences of ED in the general Danish population
(Mohr-Jensen, Vinkel Koch, Briciet Lauritsen, & Steinhausen, 2016),
the number of controls with an ED diagnosis later in time than at the
age of diagnosis of the corresponding patients with AN would have
been rather small if a less strict criterion would have been employed.
While we studied the entire range of mental disorders, the
absence of hyperkinetic disorders is noteworthy. The awareness of
this comorbidity may still have been insufficient during our study
period, particularly in adult patients (Svedlund, Norring, Ginsberg, &
von Hausswolff-Juhlin, 2017) as the frequency of hyperkinetic disor-
ders were <5 in our data, meaning that the data could not be included
in the analyses due to legislation on anonymization of data from the
Danish registers.
Other concerns related to studies based on registries are less lim-
iting. There was no independent verification of the accuracy of diag-
noses entered in the DCPRR in the present study, although prior
quality checks on the DCPRR suggest that diagnostic validity is high
across various disorders (Kessing, 1998; Lauritsen et al., 2010; Loffler
et al., 1994; Mohr-Jensen et al., 2016). However, validity studies using
structured diagnostic interviews with the patients are missing. It
should be kept in mind that the AN group in the data set was deter-
mined by treatment seeking and referral to hospital-based services.
Given that not all patients with ED seek treatment, it can be assumed
that a number of patients with AN may have contributed to a selec-
tion bias of unclear amount with an over-representation of comorbid
disorders in the patient sample. Furthermore, all patients were treated
in the public health system. There is no obligation to register data on
patients treated in the rather small sector of privately practising physi-
cians. Finally, there was an unknown but likely small number of indi-
viduals that were lost during follow-up due to emigration. Future
studies may build from the present findings and explore and disentan-
gle concurrent and sequential comorbidity, also focusing on the tem-
poral stability and predictive validity of a comorbidity-based approach
to ED classification.
In conclusion, the findings of the present study document the
excessive burden of comorbid mental disorders imposed on patients
suffering from AN. Clinically, both assessment and interventions of
comorbid mental disorders should be integrated into a highly complex
plan that goes beyond the mere consideration of AN itself. This multi-
dimensionality of care is mandatory for preventing life-damaging
courses of the disease in the afflicted patients.
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